| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| WRN |
HGNC:12791 |
Q14191 |
1-(4-Chloro-3-cyanophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea |
49853190 |
ChemBL |
| WRN |
HGNC:12791 |
Q14191 |
Oxytetracycline |
54675779 |
DGidb, DSigDB |
| WRN |
HGNC:12791 |
Q14191 |
1-[3-cyano-4-(1H-pyrazol-4-yl)phenyl]-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea |
71300295 |
ChemBL |
| WRN |
HGNC:12791 |
Q14191 |
1-(4-Bromo-3-cyanophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea |
71607477 |
ChemBL |
| WRN |
HGNC:12791 |
Q14191 |
Purpurogallin |
135403797 |
DGidb, DSigDB |
| WRN |
HGNC:12791 |
Q14191 |
indocyanine green acid form |
135564886 |
DGidb |
| WRN |
HGNC:12791 |
Q14191 |
Werner syndrome RecQ helicase-IN-1 |
166140536 |
GtoPDB |
| WRN |
HGNC:12791 |
Q14191 |
N-(4-ethylphenyl)-2-[[4-[4-(trifluoromethoxy)phenyl]-6-(trifluoromethyl)pyrimidin-2-yl]sulfonylamino]acetamide |
168476124 |
GtoPDB |
| WRN |
HGNC:12791 |
Q14191 |
N-(4-methylphenyl)-2-{4-[4-(trifluoromethoxy)phenyl]-6-(trifluoromethyl)pyrimidine-2-sulfonamido}acetamide |
169422754 |
GtoPDB |
| WRN |
HGNC:12791 |
Q14191 |
N,N-bis(4-bromophenyl)prop-2-enamide |
169422756 |
GtoPDB |
| WRN |
HGNC:12791 |
Q14191 |
N-[(E,1S)-1-cyclopropyl-3-methylsulfonylprop-2-enyl]-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide |
170717998 |
GtoPDB |
| WT1 |
HGNC:12796 |
P19544 |
Dimethyl Sulfoxide |
679 |
DGidb |
| WT1 |
HGNC:12796 |
P19544 |
Deferoxamine |
2973 |
DGidb |
| WT1 |
HGNC:12796 |
P19544 |
7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one |
400772 |
DGidb |
| WT1 |
HGNC:12796 |
P19544 |
Tretinoin |
444795 |
DGidb |
| WT1 |
HGNC:12796 |
P19544 |
Curcumin |
969516 |
DGidb |
| WT1 |
HGNC:12796 |
P19544 |
Sirolimus |
5284616 |
DGidb |
| WWOX |
HGNC:12799 |
Q9NZC7 |
Gemcitabine |
60750 |
PharmGKB |
| WWOX |
HGNC:12799 |
Q9NZC7 |
Sorafenib |
216239 |
PharmGKB |
| XBP1 |
HGNC:12801 |
P17861 |
Valproic Acid |
3121 |
PharmGKB |